Extension of Endogenous Field

  • Yoshiro Maru


Conversion between self and non-self can affect the field size for each. There are several ways by which the conversion is achieved.


Methyl Methanesulfonate Transendothelial Electrical Resistance Monophosphoryl Lipid Carboxymethyl Lysine Human Pulmonary Artery Endothelial Cell 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


  1. 1.
    Fernando RI, Litzinger M, Trono P, et al. The T-box transcription factor Brachyury promotes epithelial-mesenchymal transition in human tumor cells. J Clin Invest. 2010;120:533–44.CrossRefPubMedPubMedCentralGoogle Scholar
  2. 2.
    Palena C, Polev DE, Tsang KY, et al. The human T-box mesodermal transcription factor Brachyury is a candidate target for T-cell-mediated cancer immunotherapy. Clin Cancer Res. 2007;13:2471–8.CrossRefPubMedGoogle Scholar
  3. 3.
    Lesch M, Nyhan WL. A familial disorder of uric acid metabolism and central nervous system function. Am J Med. 1964;36:561–70.CrossRefPubMedGoogle Scholar
  4. 4.
    Sautin YY, Johnson RJ. Uric acid: the oxidant-antioxidant paradox. Nucleosides Nucleotides Nucleic Acids. 2008;27:608–19.CrossRefPubMedPubMedCentralGoogle Scholar
  5. 5.
    Schroder K, Tschopp J. The inflammasomes. Cell. 2010;140:821–32.CrossRefPubMedGoogle Scholar
  6. 6.
    Bucciantini M, Giannoni E, Chiti F, et al. Inherent toxicity of aggregates implies a common mechanism for protein misfolding diseases. Nature. 2002;416:507–11.CrossRefPubMedGoogle Scholar
  7. 7.
    Balch WE, Morimoto RI, Dillin A, et al. Adapting proteostasis for disease intervention. Science. 2008;319:916–9.CrossRefPubMedGoogle Scholar
  8. 8.
    Stefani M. Structural features and cytotoxicity of amyloid oligomers: implications in Alzheimer’s disease and other diseases with amyloid deposits. Prog Neurobiol. 2012;99:226–45.CrossRefPubMedGoogle Scholar
  9. 9.
    Halle A, Hornung V, Petzold GC, et al. The NALP3 inflammasome is involved in the innate immune response to amyloid-β. Nat Immunol. 2008;9:857–65.CrossRefPubMedPubMedCentralGoogle Scholar
  10. 10.
    Zhang C, Liu Y, Gilthorpe J, et al. MRP14 (S100A9) protein interacts with Alzheimer beta-amyloid peptide and induces its fibrillization. PLoS ONE. 2012;7:e32953.CrossRefPubMedPubMedCentralGoogle Scholar
  11. 11.
    Ha TY, Chang KA, Kim J, et al. S100a9 knockdown decreases the memory impairment and the neuropathology in Tg2576 mice, AD animal model. PLoS ONE. 2010;5:e8840.CrossRefPubMedPubMedCentralGoogle Scholar
  12. 12.
    Starosta V, Wu T, Zimman A, et al. Differential regulation of endothelial cell permeability by high and low doses of oxidized 1-palmitoyl-2-arachidonyl-sn-glycero-3-phosphocholine. Am J Respir Cell Mol Biol. 2012;46:331–41.CrossRefPubMedPubMedCentralGoogle Scholar
  13. 13.
    Bochkov VN, Kadl A, Huber J, et al. Protective role of phospholipid oxidation products in endotoxin-induced tissue damage. Nature. 2002;419:77–81.CrossRefPubMedGoogle Scholar
  14. 14.
    Oskolkova OV, Afonyushkin T, Preinerstorfer B, et al. Oxidized phospholipids are more potent antagonists of lipopolysaccharide than inducers of inflammation. J Immunol. 2010;185:7706–12.CrossRefPubMedGoogle Scholar
  15. 15.
    Von Schlieffen E, Oskolkova OV, Schabbauer G, et al. Multi-hit inhibition of circulating and cell-associated components of the toll-like receptor 4 pathway by oxidized phospholipids. Arterioscler Thromb Vasc Biol. 2009;29:356–62.CrossRefGoogle Scholar
  16. 16.
    Erridge C, Kennedy S, Spickett CM, et al. Oxidized phospholipid inhibition of toll-like receptor (TLR) signaling is restricted to TLR2 and TLR4: roles for CD14, LPS-binding protein, and MD2 as targets for specificity of inhibition. J Biol Chem. 2008;283:24748–59.CrossRefPubMedPubMedCentralGoogle Scholar
  17. 17.
    Schultz W. Getting formal with dopamine and reward. Neuron. 2002;36:241–63.CrossRefPubMedGoogle Scholar
  18. 18.
    Chapple SJ, Cheng X, Mann GE. Effects of 4-hydroxynonenal on vascular endothelial and smooth muscle cell redox signaling and function in health and disease. Redox Biol. 2013;1:319–31.CrossRefPubMedPubMedCentralGoogle Scholar
  19. 19.
    Gondokaryono SP, Ushio H, Niyonsaba F, et al. The extra domain A of fibronectin stimulates murine mast cells via Toll-like receptor 4. J Leukoc Biol. 2007;82:657–65.CrossRefPubMedGoogle Scholar
  20. 20.
    Mascarenhas MM, Day RM, Ochoa CD, et al. Low molecular weight hyaluronan from stretched lung enhances interleukin-8 expression. Am J Respir Cell Mol Biol. 2004;30:51–60.CrossRefPubMedGoogle Scholar
  21. 21.
    Itano N, Sawai T, Yoshida M, et al. Three isoforms of mammalian hyaluronan synthases have distinct enzymatic properties. J Biol Chem. 1999;274:25085–92.CrossRefPubMedGoogle Scholar
  22. 22.
    Jiang D, Liang J, Fan J, et al. Regulation of lung injury and repair by Toll-like receptors and hyaluronan. Nat Med. 2005;11:1173–9.CrossRefPubMedGoogle Scholar
  23. 23.
    Stetson DB, Medzhitov R. Recognition of cytosolic DNA activates an IRF3-dependent innate immune response. Immunity. 2006;24:93–103.CrossRefPubMedGoogle Scholar
  24. 24.
    Sirois CM, Jin T, Miller AL, et al. RAGE is a nucleic acid receptor that promotes inflammatory responses to DNA. J Exp Med. 2013;210:2447–63.CrossRefPubMedPubMedCentralGoogle Scholar
  25. 25.
    Dolovcak S, Waldrop S, Xiao F, et al. Evidence for sustained ATP release from liver cells that is not mediated by vesicular exocytosis. Purinergic Signal. 2011;7:435–46.CrossRefPubMedPubMedCentralGoogle Scholar
  26. 26.
    Figueiredo RT, Fernandez PL, Mourao-Sa DS, et al. Characterization of heme as activator of Toll-like receptor 4. J Biol Chem. 2007;282:20221–9.CrossRefPubMedGoogle Scholar
  27. 27.
    Lotze MT, Tracey KJ. High-mobility group box 1 protein (HMGB1): nuclear weapon in the immune arsenal. Nat Rev Immunol. 2005;5:331–42.CrossRefPubMedGoogle Scholar
  28. 28.
    Lange SS, Mitchell DL, Vasquez KM. High mobility group protein B1 enhances DNA repair and chromatin modification after DNA damage. Proc Natl. Acad. Sci. USA. 2008;105:10320–5.CrossRefPubMedPubMedCentralGoogle Scholar
  29. 29.
    Wang H, Bloom O, Zhang M, et al. HMG-1 as a late mediator of endotoxin lethality in mice. Science. 1999;285:248–51.CrossRefPubMedGoogle Scholar
  30. 30.
    Masaoka A, Gassman NR, Kedar PS, et al. HMGN1 protein regulates poly(ADP-ribose) polymerase-1 (PARP-1) self-PARylation in mouse fibroblasts. J Biol Chem. 2012;287:27648–58.CrossRefPubMedPubMedCentralGoogle Scholar
  31. 31.
    Yang D, Postnikov YV, Li Y, et al. High-mobility group nucleosome-binding protein 1 acts as an alarmin and is critical for lipopolysaccharide-induced immune responses. J Exp Med. 2012;209:157–71.CrossRefPubMedPubMedCentralGoogle Scholar
  32. 32.
    Brun P, Castagliuolo I, Di Leo V, et al. Increased intestinal permeability in obese mice: new evidences in the pathogenesis of nonalcoholic steatohepatitis. Am J Physiol Gastrointest Liver Physiol. 2006;292:G518–25.CrossRefPubMedGoogle Scholar
  33. 33.
    Ghanim H, Abuaysheh S, Sia CL, et al. Increase in plasma endotoxin concentrations and the expression of Toll-like receptors and suppressor of cytokine signaling-3 in mononuclear cells after a high-fat, high-carbohydrate meal: implications for insulin resistance. Diabetes Care. 2009;32:2281–7.CrossRefPubMedPubMedCentralGoogle Scholar
  34. 34.
    Maitra U, Gan L, Chang S, et al. Low-dose endotoxin induces inflammation by selectively removing nuclear receptors and activating CCAAT/enhancer-binding protein δ. J Immunol. 2011;186:4467–73.CrossRefPubMedGoogle Scholar
  35. 35.
    Shi C, Jia T, Mendez-Ferrer S, et al. Bone marrow mesenchymal stem and progenitor cells induce monocyte emigration in response to circulating Toll-like receptor ligands. Immunity. 2011;34:590–601.CrossRefPubMedPubMedCentralGoogle Scholar
  36. 36.
    Clegg CH, Roque R, Van Hoeven N, et al. Adjuvant solution for pandemic influenza vaccine production. Proc. Natl. Acad. Sci. USA. 2012;109:17585–90.CrossRefPubMedPubMedCentralGoogle Scholar
  37. 37.
    Rovere‐Querini P, Capobianco A, Scaffidi P, et al. HMGB1 is an endogenous immune adjuvant released by necrotic cells. EMBO Rep. 2004;5:825–30.CrossRefPubMedPubMedCentralGoogle Scholar
  38. 38.
    Kool M, Soullié T, Van Nimwegen M, et al. Alum adjuvant boosts adaptive immunity by inducing uric acid and activating inflammatory dendritic cells. J Exp Med. 2008;205:869–82.CrossRefPubMedPubMedCentralGoogle Scholar

Copyright information

© Springer Japan 2016

Authors and Affiliations

  • Yoshiro Maru
    • 1
  1. 1.Department of PharmacologyTokyo Women’s Medical UniversityTokyoJapan

Personalised recommendations